Diagnosis and management of melanoma in a rural general practice
Tony Townsend1 Whangamata Medical Centre, 103 Lincoln Road, Whangamata, New Zealand
Correspondence to: Tony Townsend, Whangamata Medical Centre, 103 Lincoln Road, Whangamata, New Zealand. Email: tonytownsend@outlook.com
Journal of Primary Health Care 10(3) 207-209 https://doi.org/10.1071/HC18032
Published: 13 September 2018
Journal Compilation © Royal New Zealand College of General Practitioners 2018.
This is an open access article licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Abstract
A review covering 5 years of melanoma detection and management in a small rural New Zealand practice is presented. The incidence of both in situ and invasive melanoma was approximately four-fold the national figures, which are among the highest in the world. Most melanomas can be managed in primary care but cost remains an issue.
References
[1] Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin. 1994; 44 7–26.| Cancer statistics, 1994.Crossref | GoogleScholarGoogle Scholar |
[2] Melanoma New Zealand. About melanoma. [cited 2018 February 19]. Available from: https://www.melanoma.org.nz/be-informed/understanding
[3] Guerry D, Synnestvedt M, Elder DE, Schultz D. Lessons from tumour progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J Invest Dermatol. 1993; 100 S342–S345.
| Lessons from tumour progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent.Crossref | GoogleScholarGoogle Scholar |
[4] Skin Cancer Foundation. Skin cancer facts and statistics. [cited 2018 February 19]. Available from: https://www.skincancer.org/skin-cancer-information/skin-cancer-facts#melanoma
[5] Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand. Sydney: Cancer Council Australia and Australian Cancer Network; and Wellington: New Zealand Guidelines Group; 2008: 73–77.
[6] Whiteman DC, Green AC, Olsen CM. The growing burden of invasive melanoma: Projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Invest Dermatol. 2016; 136 1161–71.
| The growing burden of invasive melanoma: Projections of incidence rates and numbers of new cases in six susceptible populations through 2031.Crossref | GoogleScholarGoogle Scholar |
